View this email in your browser

Vaccine-preventable diseases and
immunization programme

OCTOBER 2021

In this issue

The European Immunization Agenda 2030

EU and WHO joint action on COVID-19

The 71st Regional Committee for Europe adopted on 14 September the European Immunization Agenda 2030.
This issue of the VPI newsletter focuses on this new strategy for the coming decade and new resources produced by WHO/Europe to support Member States and health workers in deployment of COVID-19 vaccines. It also showcases news and publications related to other vaccine-preventable diseases.

The European Immunization Agenda 2030 (EIA2030)

Countries of the WHO European Region adopt new regional immunization agenda for coming decade

14 September 2021 - An ambitious strategy to ensure equitable and life-long protection from vaccine-preventable diseases was adopted by the 71st session of the WHO Regional Committee for Europe.

A bottom-up approach to build back better
The COVID-19 pandemic has had a profound impact on health systems, including in the area of routine vaccinations. EIA2030 was formulated through a consultative process involving Member States and partners to build forward stronger, by creating more resilient immunization systems and structures. It is based on lessons learned and the key pillars of immunization equity, life-course immunization and tailored local solutions that address vaccination demand and acceptance in the population. EIA2030 is one of the flagship initiatives of the European Programme of Work, 2020–2025 – “United Action for Better Health in Europe”. Read more

Partner insights – European Immunization Agenda 2030
Introduction to a new strategy for joint action

European Immunization Agenda 2030: draft for the Seventy-first Regional Committee for Europe

This Draft document is prepared for the Seventy-first Regional Committee for Europe. The European Immunization Agenda 2030 (EIA2030), a vision and strategy crafted by Member Statesfor achieving the full benefits of immunization in the WHO European Region for the next decade,builds on the achievements and lessons learned from implementation of the European Vaccine ActionPlan 2015–2020 (EVAP).

European Immunization Agenda 2030 – illustrated explainer

COVID-19 vaccination

Statement – WHO/Europe: stagnating COVID-19 vaccination uptake requires urgent action

Copenhagen, 30 August 2021, Dr Hans Henri P. Kluge, WHO Regional Director for Europe

The epidemiological picture in the WHO European Region, comprising 53 countries, is mixed. We now have 64 million confirmed cases and 1.3 million deaths. Thirty-three Member States report a greater than 10% increase in 14-day case incidence. This high transmission is deeply worrying – particularly in the light of low vaccination uptake in priority populations in a number of countries.

Full statement

Statement video

EU and WHO joint action on COVID-19 vaccine deployment and vaccination

Project information: European Union (EU)-WHO/Europe Action to support deployment of COVID-19 vaccines and vaccination

News: European Union and WHO deliver medical refrigerators for vaccine storage to Armenia

Moldovan pharmacies contribute to pandemic response as a reliable source of information on COVID-19 vaccination

Resources on COVID-19 vaccines and vaccination for health workers

Training package: Communicating with patients about
COVID-19 vaccination

AZD1222 (ChAdOx1-S [recombinant]) COVID-19 vaccine

Comirnaty® Pfizer/BioNTech BNT162b2 vaccine

Janssen–Cilag International NV (Belgium) Ad26.COV2.S COVID-19 vaccine

Training package: Communicating with health workers about
COVID-19 vaccination

Moderna COVID-19 (mRNA-1273) vaccine

Sinopharm COVID-19 vaccines

Sinovac-CoronaVac COVID-19 vaccine

VIDEOS: COVID-19 vaccines and vaccination explained

Videos and podcast for health workers and the public to address common questions about COVID-19 vaccines. Available in English, Russian, Spanish, Czech and Ukrainian.

Visit: www.covid19infovaccines.com

COVID-19 vaccine uptake monitoring

WHO/Europe and the European Centre for Disease Prevention and Control (ECDC) launched joint monitoring of COVID-19 vaccine uptake in the Region in January 2020. This is intended to guide development and, if needed, revision of national vaccination strategies by monitoring: access to COVID-19 vaccination, efficiency of vaccination campaigns and trends within the region.

WHO/Europe COVID-19 Vaccine Programme Monitor

News

Conclusions of the 9th meeting of the European Regional Verification Commission for Measles and Rubella Elimination (RVC)

Tajikistan completes second round of immunization campaign against circulating poliovirus

WHO/Europe shows high rates of COVID-19 vaccination in prisons

Refugees and migrants hosted in Serbian reception centres get their COVID-19 vaccine doses

One case of polio detected in Ukraine

Other resources

EpiData 9/2021

EpiData provides a monthly overview of surveillance data on selected vaccine-preventable diseases reported by Member States in the European Region.
EpiData 9/2021 covers data for the period September 2020—August 2021 (data as of 30 September 2021)

Reducing risk of Poliomeylitis outbreaks in emergencies – 2021 Interim update

| English | French | Russian |

CONTACT US

Vaccine-preventable diseases and immunization (VPI)
WHO Regional Office for Europe
UN City, Marmorvej 51
DK-2100 Copenhagen, Denmark
Email: euvaccine@who.int

Website: www.euro.who.int/immunization